Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage. 2016

Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an 710032, China.

Diabetic nephropathy (DN) is one of the major complications of diabetes mellitus (DM). This study aimed to explore the effects of corosolic acid (CA) on the renal damage of DM and the mechanisms behind these effects. The renoprotective effect of CA was investigated in type 1 diabetic rats and db/db mice. The kidneys and glomerular mesangial cells (GMCs) were used to study the proliferation of GMCs by immunostaining and MTT assay. Further immunoblotting, siRNA, qPCR analysis, and detecting of NADPH oxidase activity and reactive oxygen species (ROS) generation were performed to explore relevant molecular mechanisms. In CA-treated diabetic animals, diabetes-induced albuminuria, increased serum creatinine and blood urea nitrogen were significantly attenuated, and glomerular hypertrophy, mesangial expansion and fibrosis were ameliorated. Furthermore, CA significantly inhibited proliferation of GMCs and phosphorylation of ERK1/2 and p38 MAPK in both diabetic animals and high glucose (HG)-induced GMCs. CA also normalized Δψm and inhibited HG-induced NADPH oxidase activity, ROS generation and NOX4, NOX2, p22(phox) and p47(phox) expression. More importantly, CA inhibited GMC proliferation mediated by NADPH/ERK1/2 and p38 MAPK signaling pathways. These findings suggest that CA exert the protective effect on DN by anti-proliferation resulted from inhibition of p38 MAPK- and NADPH-mediated inactivation of ERK1/2.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D050527 Mesangial Cells Smooth muscle-like cells adhering to the wall of the small blood vessels of the KIDNEY at the glomerulus and along the vascular pole of the glomerulus in the JUXTAGLOMERULAR APPARATUS. They are myofibroblasts with contractile and phagocytic properties. These cells and their MESANGIAL EXTRACELLULAR MATRIX constitute the GLOMERULAR MESANGIUM. Glomerular Mesangial Cells,Extraglomerular Mesangial Cells,Lacis Cells,Mesangial Cells, Kidney,Renal Glomerulus Mesangial Cells,Renal Mesangial Cells,Cell, Extraglomerular Mesangial,Cell, Glomerular Mesangial,Cell, Kidney Mesangial,Cell, Lacis,Cell, Mesangial,Cell, Renal Mesangial,Cells, Extraglomerular Mesangial,Cells, Glomerular Mesangial,Cells, Kidney Mesangial,Cells, Lacis,Cells, Mesangial,Cells, Renal Mesangial,Extraglomerular Mesangial Cell,Glomerular Mesangial Cell,Kidney Mesangial Cell,Kidney Mesangial Cells,Lacis Cell,Mesangial Cell,Mesangial Cell, Extraglomerular,Mesangial Cell, Glomerular,Mesangial Cell, Kidney,Mesangial Cell, Renal,Mesangial Cells, Extraglomerular,Mesangial Cells, Glomerular,Mesangial Cells, Renal,Renal Mesangial Cell

Related Publications

Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
January 1994, Life sciences,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
November 2012, Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
November 2016, Oncology letters,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
April 1998, Zhonghua yi xue za zhi,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
March 2010, Phytotherapy research : PTR,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
April 1997, Kidney international,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
March 1975, Biulleten' eksperimental'noi biologii i meditsiny,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
May 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
November 2016, European journal of pharmacology,
Xiao-Qiang Li, and Wen Tian, and Xiao-Xiao Liu, and Kai Zhang, and Jun-Cheng Huo, and Wen-Juan Liu, and Ping Li, and Xiong Xiao, and Ming-Gao Zhao, and Wei Cao
September 2005, Life sciences,
Copied contents to your clipboard!